English
Insider transactions
EDGARAtara Biotherapeutics, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-20.
- Open-market purchases (code P)
- 2 transactions, 611,573 shares
- Sum of shares × price per share: 5,744,249.05
- Open-market sales (code S)
- 14 transactions, 417,911 shares
- Sum of shares × price per share: 3,830,100.6227
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–33 of 33
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 Filed 2026-11-18 | Nguyen AnhCo Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,094 | 6.4602 | 39,368.4588Derived: shares × price per share. Exact value 39368.4588. | 126,681 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-005037 Read from the filing’s XML Dispute this row |
| 2026-09-04 Filed 2026-09-04 | Cherry Brian N Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 104,166 | 9.60 | 999,993.6Derived: shares × price per share. Exact value 999993.60. | 166,486 | Direct (D) | No | F1
| Open filing 0000905148-26-004085 Read from the filing’s XML Dispute this row |
| 2026-08-17 Filed 2026-08-26 | Nguyen AnhCo Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,062 | 8.0764 | 40,882.7368Derived: shares × price per share. Exact value 40882.7368. | 132,775 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-003960 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-07-24 | Redmile Group, LLC DirectorGreen Jeremy Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 195,211 | — | — | 636,912 | Indirect (I) See Footnote | No | F5, F4
| Open filing 0001104659-26-086733 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-07-24 | Redmile Group, LLC DirectorGreen Jeremy Director | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 60 | — | — | 636,852 | Indirect (I) See Footnote | No | F5, F4
| Open filing 0001104659-26-086733 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-07-24 | Redmile Group, LLC DirectorGreen Jeremy Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 101,089 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 0 | Indirect (I) See Footnote | No | F1, F8, F5, F4
| Open filing 0001104659-26-086733 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-07-24 | Redmile Group, LLC DirectorGreen Jeremy Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 38,735 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 0 | Indirect (I) See Footnote | No | F2, F8, F5, F4
| Open filing 0001104659-26-086733 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-07-24 | Redmile Group, LLC DirectorGreen Jeremy Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 55,387 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 0 | Indirect (I) See Footnote | No | F3, F8, F5, F4
| Open filing 0001104659-26-086733 Read from the filing’s XML Dispute this row |
| 2026-06-11 Filed 2026-06-15 | Cherry Brian N Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 24,000 | 0 | — | 62,320 | Direct (D) | No | F1
| Open filing 0000905148-26-002951 Read from the filing’s XML Dispute this row |
| 2026-06-09 Filed 2026-06-11 | HEIDEN WILLIAM K Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,000 | 0 | — | 34,188 | Direct (D) | No | F1
| Open filing 0000905148-26-002921 Read from the filing’s XML Dispute this row |
| 2026-06-09 Filed 2026-06-11 | Ciongoli Gregory Austin Director · 10% owner · Other: See Remarks | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,000 | 0 | — | 12,000 | Direct (D) | No | F1
| Open filing 0000905148-26-002919 Read from the filing’s XML Dispute this row |
| 2026-06-09 Filed 2026-06-11 | Fust Matthew K Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,000 | 0 | — | 30,188 | Direct (D) | No | F1
| Open filing 0000905148-26-002920 Read from the filing’s XML Dispute this row |
| 2026-05-18 Filed 2026-05-20 | Nguyen AnhCo Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,241 | 9.1289 | 47,844.5649Derived: shares × price per share. Exact value 47844.5649. | 137,837 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-002571 Read from the filing’s XML Dispute this row |
| 2026-05-18 Filed 2026-05-20 | Grant-Huerta Yanina Officer: Chief Accounting Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,414 | 9.1286 | 22,036.4404Derived: shares × price per share. Exact value 22036.4404. | 49,636 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-002570 Read from the filing’s XML Dispute this row |
| 2026-05-07 Filed 2026-05-11 | Panacea Innovation Ltd 10% ownerHuang James Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 313,446 | 10.0975 | 3,165,020.985Derived: shares × price per share. Exact value 3165020.9850. | 1,011,000 | Indirect (I) See Footnote | No | F1, F2, F3
| Open filing 0001193125-26-217380 Read from the filing’s XML Dispute this row |
| 2026-05-07 Filed 2026-05-11 | EcoR1 Capital, LLC 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 507,407 | 9.35 | 4,744,255.45Derived: shares × price per share. Exact value 4744255.45. | 1,552,000 | Indirect (I) See Note | No | F2, F3, F4, F1
| Open filing 0000935836-26-000239 Read from the filing’s XML Dispute this row |
| 2026-03-17 Filed 2026-03-19 | Panacea Innovation Ltd 10% ownerHuang James Director · 10% owner | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 259,163 | 0.0001 | 25.9163Derived: shares × price per share. Exact value 25.9163. | 307,899 | Indirect (I) See Footnotes | No | F1, F2
| Open filing 0001193125-26-116060 Read from the filing’s XML Dispute this row |
| 2026-03-17 Filed 2026-03-19 | Panacea Innovation Ltd 10% ownerHuang James Director · 10% owner | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 5 | 5.23 | 26.15Derived: shares × price per share. Exact value 26.15. | 307,894 | Indirect (I) See Footnotes | No | F1, F2
| Open filing 0001193125-26-116060 Read from the filing’s XML Dispute this row |
| 2026-03-17 Filed 2026-03-19 | Panacea Innovation Ltd 10% ownerHuang James Director · 10% owner | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 259,163 | 6.6099 | 1,713,041.5137Derived: shares × price per share. Exact value 1713041.5137. | 0 | Indirect (I) See Footnotes | No | F4, F1, F2
| Open filing 0001193125-26-116060 Read from the filing’s XML Dispute this row |
| 2026-03-09 Filed 2026-03-11 | Grant-Huerta Yanina Officer: Chief Accounting Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 20,300 | 0 | — | 52,050 | Direct (D) | No | F1
| Open filing 0000905148-26-001224 Read from the filing’s XML Dispute this row |
| 2026-03-09 Filed 2026-03-11 | Nguyen AnhCo Director · Officer: President and CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 81,100 | 0 | — | 143,078 | Direct (D) | No | F1
| Open filing 0000905148-26-001225 Read from the filing’s XML Dispute this row |
| 2026-03-02 Filed 2026-03-04 | Nguyen AnhCo Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 198 | 5.079 | 1,005.642Derived: shares × price per share. Exact value 1005.642. | 64,776 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-001143 Read from the filing’s XML Dispute this row |
| 2026-03-02 Filed 2026-03-04 | Nguyen AnhCo Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 58 | 5.08 | 294.64Derived: shares × price per share. Exact value 294.64. | 64,718 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-001143 Read from the filing’s XML Dispute this row |
| 2026-03-02 Filed 2026-03-04 | Nguyen AnhCo Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,298 | 5.086 | 6,601.628Derived: shares × price per share. Exact value 6601.628. | 63,420 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-001143 Read from the filing’s XML Dispute this row |
| 2026-03-02 Filed 2026-03-04 | Nguyen AnhCo Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,442 | 5.087 | 7,335.454Derived: shares × price per share. Exact value 7335.454. | 61,978 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-001143 Read from the filing’s XML Dispute this row |
| 2026-03-02 Filed 2026-03-04 | Grant-Huerta Yanina Officer: Chief Accounting Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 24 | 5.077 | 121.848Derived: shares × price per share. Exact value 121.848. | 33,830 | Direct (D) | No | F1, F2, F3
| Open filing 0000905148-26-001144 Read from the filing’s XML Dispute this row |
| 2026-03-02 Filed 2026-03-04 | Grant-Huerta Yanina Officer: Chief Accounting Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,603 | 5.081 | 8,144.843Derived: shares × price per share. Exact value 8144.843. | 32,227 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-001144 Read from the filing’s XML Dispute this row |
| 2026-03-02 Filed 2026-03-04 | Grant-Huerta Yanina Officer: Chief Accounting Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 377 | 5.082 | 1,915.914Derived: shares × price per share. Exact value 1915.914. | 31,850 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-001144 Read from the filing’s XML Dispute this row |
| 2026-03-02 Filed 2026-03-04 | Grant-Huerta Yanina Officer: Chief Accounting Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 100 | 5.083 | 508.3Derived: shares × price per share. Exact value 508.300. | 31,750 | Direct (D) | No | F1, F2
| Open filing 0000905148-26-001144 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | Panacea Innovation Ltd 10% ownerHuang James Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 80,554 | 6.0707 | 489,019.1678Derived: shares × price per share. Exact value 489019.1678. | 1,324,446 | Indirect (I) See Footnotes | No | F3, F1, F2
| Open filing 0001193125-26-013358 Read from the filing’s XML Dispute this row |
| 2025-11-28 Filed 2025-12-01 | Panacea Innovation Ltd 10% ownerHuang James Director · 10% owner | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 48,737 | 0.0001 | 4.8737Derived: shares × price per share. Exact value 4.8737. | 48,737 | Indirect (I) See Footnotes | No | F1, F2
| Open filing 0001193125-25-304018 Read from the filing’s XML Dispute this row |
| 2025-11-28 Filed 2025-12-01 | Panacea Innovation Ltd 10% ownerHuang James Director · 10% owner | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 1 | 14.03 | 14.03Derived: shares × price per share. Exact value 14.03. | 48,736 | Indirect (I) See Footnotes | No | F1, F2
| Open filing 0001193125-25-304018 Read from the filing’s XML Dispute this row |
| 2025-11-28 Filed 2025-12-01 | Panacea Innovation Ltd 10% ownerHuang James Director · 10% owner | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 48,737 | 6.6099 | 322,146.6963Derived: shares × price per share. Exact value 322146.6963. | 259,163 | Indirect (I) See Footnotes | No | F4, F1, F2
| Open filing 0001193125-25-304018 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.
Showing 1–37 of 37
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| EcoR1 Capital, LLC | 1,552,000 SH | 13,192,000 dollars | Unchanged Prior quarter: 1,552,000 | Open filing 0000935836-26-000577 Filed 2026-11-16 Dispute this row |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 850,000 SH | 7,225,000 dollars | Unchanged Prior quarter: 850,000 | Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row |
| Point72 Asset Management, L.P. | 677,696 SH | 5,760,416 dollars | Lower by 10,022 Prior quarter: 687,718 | Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row |
| Redmile Group, LLC | 636,852 SH | 5,413,242 dollars | Higher by 195,151 Prior quarter: 441,701 | Open filing 0000905148-26-004923 Filed 2026-11-16 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 247,047 SH | 2,099,900 dollars | Unchanged Prior quarter: 247,047 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| MACKENZIE FINANCIAL CORP | 176,758 SH | 1,502,443 dollars | Lower by 56,491 Prior quarter: 233,249 | Open filing 0001062993-26-005652 Filed 2026-11-02 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 85,302 SH | 725,068 dollars | Higher by 847 Prior quarter: 84,455 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 80,950 SH | 688,416 dollars | Higher by 5,822 Prior quarter: 75,128 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 50,703 SH | 430,976 dollars | Higher by 7,667 Prior quarter: 43,036 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| STALEY CAPITAL ADVISERS INC | 50,000 SH | 425,000 dollars | Unchanged Prior quarter: 50,000 | Open filing 0001106565-26-000010 Filed 2026-11-06 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 43,079 SH | 366,172 dollars | Higher by 32,920 Prior quarter: 10,159 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 26,453 SH | 224,851 dollars | Unchanged Prior quarter: 26,453 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| UBS Group AG Partly reported under another manager | 20,756 SH | 176,426 dollars | Higher by 16,777 Prior quarter: 3,979 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 16,705 SH | 141,993 dollars | Higher by 114 Prior quarter: 16,591 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| FMR LLC Partly reported under another manager | 16,278 SH | 138,363 dollars | Higher by 40 Prior quarter: 16,238 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| Empowered Funds, LLC Partly reported under another manager | 13,760 SH | 116,960 dollars | Not in the prior quarter’s filings read | Open filing 0001592828-26-000008 Filed 2026-11-13 Dispute this row |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 13,760 SH | 116,960 dollars | Lower by 240 Prior quarter: 14,000 | Open filing 0001107261-26-000007 Filed 2026-11-16 Dispute this row |
| ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager | 11,538 SH | 98 dollars | Lower by 27,307 Prior quarter: 38,845 | Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 9,176 SH | 77,997 dollars | Lower by 2 Prior quarter: 9,178 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| ROYAL BANK OF CANADA Partly reported under another manager | 8,751 SH | 74,000 dollars | Higher by 4,008 Prior quarter: 4,743 | Open filing 0001140361-26-044123 Filed 2026-11-16 Dispute this row |
| Employees Retirement System of Texas | 5,154 SH | 44 dollars | Not in the prior quarter’s filings read | Open filing 0001398739-26-000013 Filed 2026-11-10 Dispute this row |
| Vanguard Global Advisers, LLC | 4,654 SH | 39,559 dollars | Higher by 3,198 Prior quarter: 1,456 | Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row |
| SBI Securities Co., Ltd. | 1,404 SH | 11,934 dollars | Unchanged Prior quarter: 1,404 | Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row |
| JONES FINANCIAL COMPANIES LLLP Partly reported under another manager | 303 SH | 2,669 dollars | Lower by 500 Prior quarter: 803 | Open filing 0001193125-26-459442 Filed 2026-11-13 Dispute this row |
| Caitong International Asset Management Co., Ltd | 266 SH | 2,261 dollars | Lower by 45 Prior quarter: 311 | Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row |
| WELLS FARGO COMPANY/MN Partly reported under another manager | 251 SH | 2,134 dollars | Unchanged Prior quarter: 251 | Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 222 SH | 1,787 dollars | Higher by 6 Prior quarter: 216 | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| Tower Research Capital LLC (TRC) Partly reported under another manager | 221 SH | 1,879 dollars | Not in the prior quarter’s filings read | Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row |
| BARCLAYS PLC Partly reported under another manager | 214 SH | 1,819 dollars | Lower by 90 Prior quarter: 304 | Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row |
| Raiffeisen Bank International AG Option: Call Partly reported under another manager | 200 SH | 1,700 dollars | Unchanged Prior quarter: 200 | Open filing 0002044885-26-000005 Filed 2026-10-28 Dispute this row |
| BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager | 46 SH | 391 dollars | Unchanged Prior quarter: 46 | Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row |
| PlanVest Financial, Inc Partly reported under another manager | 28 SH | 238 dollars | Unchanged Prior quarter: 28 | Open filing 0002135239-26-000005 Filed 2026-11-09 Dispute this row |
| KERR FINANCIAL PLANNING Corp | 24 SH | 204 dollars | Unchanged Prior quarter: 24 | Open filing 0002095947-26-000008 Filed 2026-11-17 Dispute this row |
| OSAIC HOLDINGS, INC. Partly reported under another manager | 10 SH | 80 dollars | Unchanged Prior quarter: 10 | Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row |
| Rockefeller Capital Management L.P. Partly reported under another manager | 8 SH | 68 dollars | Unchanged Prior quarter: 8 | Open filing 0001739439-26-000009 Filed 2026-11-13 Dispute this row |
| CITIGROUP INC Partly reported under another manager | 1 SH | 9 dollars | Lower by 96 Prior quarter: 97 | Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row |
| IFP Advisors, Inc Partly reported under another manager | 1 SH | 8 dollars | Not in the prior quarter’s filings read | Open filing 0001641866-26-000005 Filed 2026-10-16 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- JANE STREET GROUP, LLC 30,345 SH
- XTX Topco Ltd 15,303 SH
- MILLENNIUM MANAGEMENT LLC 12,680 SH
- Banque Transatlantique SA 176 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Redmile Group, LLC Common Stock, par value $0.0001 per share | 9.9 | 950,994.00 | 07/22/2026 Filed 2026-07-24 | SCHEDULE 13D/AAmendment 3 | Open filing 0001104659-26-086728 Dispute this row |
| Green Jeremy Common Stock, par value $0.0001 per share | 9.9 | 950,994.00 | 07/22/2026 Filed 2026-07-24 | SCHEDULE 13D/AAmendment 3 | Open filing 0001104659-26-086728 Dispute this row |
| Redmile Biopharma Investments II, L.P. Common Stock, par value $0.0001 per share | 6.6 | 631,020.00 | 07/22/2026 Filed 2026-07-24 | SCHEDULE 13D/AAmendment 3 | Open filing 0001104659-26-086728 Dispute this row |
| Redmile Strategic Long Only Trading Sub, Ltd. Common Stock, par value $0.0001 per share | 4.2 | 401,901.00 | 07/22/2026 Filed 2026-07-24 | SCHEDULE 13D/AAmendment 3 | Open filing 0001104659-26-086728 Dispute this row |
| Point72 Asset Management, L.P. Common Stock, par value $0.0001 per share | 7.6 | 687,718.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-005481 Dispute this row |
| Point72 Capital Advisors, Inc. Common Stock, par value $0.0001 per share | 7.6 | 687,718.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-005481 Dispute this row |
| Steven A. Cohen Common Stock, par value $0.0001 per share | 7.6 | 687,718.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-005481 Dispute this row |
| Redmile Group, LLC Common Stock, par value $0.0001 per share | 9.9 | 950,994.00 | 05/12/2026 Filed 2026-05-14 | SCHEDULE 13D/AAmendment 2 | Open filing 0001104659-26-061506 Dispute this row |
| Jeremy C. Green Common Stock, par value $0.0001 per share | 9.9 | 950,994.00 | 05/12/2026 Filed 2026-05-14 | SCHEDULE 13D/AAmendment 2 | Open filing 0001104659-26-061506 Dispute this row |
| Redmile Biopharma Investments II, L.P. Common Stock, par value $0.0001 per share | 6.9 | 651,924.00 | 05/12/2026 Filed 2026-05-14 | SCHEDULE 13D/AAmendment 2 | Open filing 0001104659-26-061506 Dispute this row |
| Redmile Strategic Long Only Trading Sub, Ltd. Common Stock, par value $0.0001 per share | 6.1 | 576,148.00 | 05/12/2026 Filed 2026-05-14 | SCHEDULE 13D/AAmendment 2 | Open filing 0001104659-26-061506 Dispute this row |
| Panacea Innovation Limited Common Stock | 16.1 | 1,318,894 | 05/07/2026 Filed 2026-05-11 | SCHEDULE 13D/AAmendment 3 | Open filing 0001193125-26-217389 Dispute this row |
| Panacea Venture Healthcare Fund II, L.P. Common Stock | 12.4 | 1,011,000 | 05/07/2026 Filed 2026-05-11 | SCHEDULE 13D/AAmendment 3 | Open filing 0001193125-26-217389 Dispute this row |
| Panacea Venture Healthcare Fund II GP Company, Ltd. Common Stock | 12.4 | 1,011,000 | 05/07/2026 Filed 2026-05-11 | SCHEDULE 13D/AAmendment 3 | Open filing 0001193125-26-217389 Dispute this row |
| Panacea Opportunity Fund I, L.P. Common Stock | 3.8 | 307,899 | 05/07/2026 Filed 2026-05-11 | SCHEDULE 13D/AAmendment 3 | Open filing 0001193125-26-217389 Dispute this row |
| Panacea Opportunity Fund I GP Company, Ltd. Common Stock | 3.8 | 307,899 | 05/07/2026 Filed 2026-05-11 | SCHEDULE 13D/AAmendment 3 | Open filing 0001193125-26-217389 Dispute this row |
| James Huang Common Stock | 16.1 | 1,318,894 | 05/07/2026 Filed 2026-05-11 | SCHEDULE 13D/AAmendment 3 | Open filing 0001193125-26-217389 Dispute this row |
| Point72 Asset Management, L.P. Common Stock, par value $0.0001 per share | 6.2 | 526,682.00 | 05/07/2026 Filed 2026-05-08 | SCHEDULE 13G | Open filing 0000919574-26-002802 Dispute this row |
| Point72 Capital Advisors, Inc. Common Stock, par value $0.0001 per share | 6.2 | 526,682.00 | 05/07/2026 Filed 2026-05-08 | SCHEDULE 13G | Open filing 0000919574-26-002802 Dispute this row |
| Steven A. Cohen Common Stock, par value $0.0001 per share | 6.2 | 526,682.00 | 05/07/2026 Filed 2026-05-08 | SCHEDULE 13G | Open filing 0000919574-26-002802 Dispute this row |
| EcoR1 Capital, LLC Common Stock | 17.4 | 1,552,000.00 | 05/07/2026 Filed 2026-05-07 | SCHEDULE 13G/AAmendment 3 | Open filing 0000935836-26-000230 Dispute this row |
| Oleg Nodelman Common Stock | 17.4 | 1,552,000.00 | 05/07/2026 Filed 2026-05-07 | SCHEDULE 13G/AAmendment 3 | Open filing 0000935836-26-000230 Dispute this row |
| EcoR1 Capital Fund Qualified, L.P. Common Stock | 16.2 | 1,445,609.00 | 05/07/2026 Filed 2026-05-07 | SCHEDULE 13G/AAmendment 3 | Open filing 0000935836-26-000230 Dispute this row |
| Adage Capital Management, L.P. Common Stock, par value $0.0001 per share | 8.56 | 700,000.00 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G | Open filing 0000919574-26-002914 Dispute this row |
| Robert Atchinson Common Stock, par value $0.0001 per share | 8.56 | 700,000.00 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G | Open filing 0000919574-26-002914 Dispute this row |
| Phillip Gross Common Stock, par value $0.0001 per share | 8.56 | 700,000.00 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G | Open filing 0000919574-26-002914 Dispute this row |
| Panacea Innovation Limited Common Stock | 19.99 | 1,632,345 | 01/12/2026 Filed 2026-01-14 | SCHEDULE 13D/AAmendment 2 | Open filing 0001193125-26-013362 Dispute this row |
| Panacea Venture Healthcare Fund II, L.P. Common Stock | 18.2 | 1,324,446 | 01/12/2026 Filed 2026-01-14 | SCHEDULE 13D/AAmendment 2 | Open filing 0001193125-26-013362 Dispute this row |
| Panacea Venture Healthcare Fund II GP Company, Ltd. Common Stock | 18.2 | 1,324,446 | 01/12/2026 Filed 2026-01-14 | SCHEDULE 13D/AAmendment 2 | Open filing 0001193125-26-013362 Dispute this row |
| Panacea Opportunity Fund I, L.P. Common Stock | 4.1 | 307,899 | 01/12/2026 Filed 2026-01-14 | SCHEDULE 13D/AAmendment 2 | Open filing 0001193125-26-013362 Dispute this row |
| Panacea Opportunity Fund I GP Company, Ltd. Common Stock | 4.1 | 307,899 | 01/12/2026 Filed 2026-01-14 | SCHEDULE 13D/AAmendment 2 | Open filing 0001193125-26-013362 Dispute this row |
| James Huang Common Stock | 19.99 | 1,632,345 | 01/12/2026 Filed 2026-01-14 | SCHEDULE 13D/AAmendment 2 | Open filing 0001193125-26-013362 Dispute this row |
| Redmile Group, LLC Common Stock, par value $0.0001 per share | 9.9 | 751,223.00 | 11/12/2025 Filed 2025-11-14 | SCHEDULE 13D/AAmendment 1 | Open filing 0001104659-25-112574 Dispute this row |
| Jeremy C. Green Common Stock, par value $0.0001 per share | 9.9 | 751,223.00 | 11/12/2025 Filed 2025-11-14 | SCHEDULE 13D/AAmendment 1 | Open filing 0001104659-25-112574 Dispute this row |
| RedCo I, L.P. Common Stock, par value $0.0001 per share | 4.7 | 347,442.00 | 11/12/2025 Filed 2025-11-14 | SCHEDULE 13D/AAmendment 1 | Open filing 0001104659-25-112574 Dispute this row |
| Redmile Biopharma Investments II, L.P. Common Stock, par value $0.0001 per share | 6.0 | 452,153.00 | 11/12/2025 Filed 2025-11-14 | SCHEDULE 13D/AAmendment 1 | Open filing 0001104659-25-112574 Dispute this row |
| Redmile Strategic Long Only Trading Sub, Ltd. Common Stock, par value $0.0001 per share | 5.0 | 376,377.00 | 11/12/2025 Filed 2025-11-14 | SCHEDULE 13D/AAmendment 1 | Open filing 0001104659-25-112574 Dispute this row |
| EcoR1 Capital, LLC Common Stock | 9.9 | 715,853.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000935836-25-000703 Dispute this row |
| Oleg Nodelman Common Stock | 9.9 | 715,853.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000935836-25-000703 Dispute this row |
| EcoR1 Capital Fund Qualified, L.P. Common Stock | 9.3 | 667,639.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000935836-25-000703 Dispute this row |
| Panacea Innovation Limited Common Stock | 20.0 | 1,712,900 | 08/15/2025 Filed 2025-08-19 | SCHEDULE 13D/AAmendment 1 | Open filing 0000950170-25-110311 Dispute this row |
| Panacea Venture Healthcare Fund II, L.P. Common Stock | 20.0 | 1,405,000 | 08/15/2025 Filed 2025-08-19 | SCHEDULE 13D/AAmendment 1 | Open filing 0000950170-25-110311 Dispute this row |
| Panacea Venture Healthcare Fund II GP Company, Ltd. Common Stock | 20.0 | 1,405,000 | 08/15/2025 Filed 2025-08-19 | SCHEDULE 13D/AAmendment 1 | Open filing 0000950170-25-110311 Dispute this row |
| Panacea Opportunity Fund I, L.P. Common Stock | 4.2 | 307,900 | 08/15/2025 Filed 2025-08-19 | SCHEDULE 13D/AAmendment 1 | Open filing 0000950170-25-110311 Dispute this row |
| Panacea Opportunity Fund I GP Company, Ltd. Common Stock | 4.2 | 307,900 | 08/15/2025 Filed 2025-08-19 | SCHEDULE 13D/AAmendment 1 | Open filing 0000950170-25-110311 Dispute this row |
| James Huang Common Stock | 20.0 | 1,712,900 | 08/15/2025 Filed 2025-08-19 | SCHEDULE 13D/AAmendment 1 | Open filing 0000950170-25-110311 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,641,447 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 58,534 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,123 |
Filings made before the SEC required XML are listed, not extracted.